Pyxis IPO leads way as four life science firms kick off 4Q, raising nearly $500M

Healthcare

Pyxis Oncology’s IPO raised $168 million as the biotech steers toward the clinic with drug candidates and technology licensed from Pfizer. Theseus Pharma, IsoPlexis, and Cognition Therapeutics also went public; combined the four companies raised nearly half a billion dollars.

Leave a Reply